Free Trial
TSE:PMN

ProMIS Neurosciences (PMN) Stock Price, News & Analysis

ProMIS Neurosciences logo

About ProMIS Neurosciences Stock (TSE:PMN)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
19,701 shs
Average Volume
3,327 shs
Market Capitalization
C$51.48 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive PMN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for ProMIS Neurosciences and its competitors with MarketBeat's FREE daily newsletter.

PMN Stock News Headlines

Elon’s BIGGEST warning yet?
Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… The "experts" said Elon was finished and Tesla was headed for bankruptcy. Now they're saying the same thing, but Jeff has uncovered Tesla's next breakthrough.
ProMIS Neurosciences initiates Phase 1b trial in Alzheimer’s disease
See More Headlines

PMN Stock Analysis - Frequently Asked Questions

Shares of PMN stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.

Based on aggregate information from My MarketBeat watchlists, some other companies that ProMIS Neurosciences investors own include CRISPR Therapeutics (CRSP), Aurora Cannabis (ACB), Keurig Dr Pepper (KDP), Biocept (BIOC), Onconova Therapeutics (ONTX), Spectra7 Microsystems (SEV) and TherapeuticsMD (TXMD).

Industry, Sector and Symbol

Stock Exchange
TSE
Sector
Medical
Industry
Biotechnology
Sub-Industry
N/A
Current Symbol
TSE:PMN
Previous Symbol
TSE:AMF
CIK
N/A
Fax
N/A
Employees
6
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
C($3.38)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-C$20.93 million
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
-837.71%
Return on Assets
-168.33%

Debt

Debt-to-Equity Ratio
108.33
Current Ratio
0.51
Quick Ratio
1.30

Sales & Book Value

Annual Sales
C$7.56 thousand
Price / Sales
0.00
Cash Flow
N/A
Price / Cash Flow
14.07
Book Value
C($0.72) per share
Price / Book
N/A

Miscellaneous

Outstanding Shares
8,580,000
Free Float
N/A
Market Cap
C$51.48 million
Optionable
Not Optionable
Beta
1.19
The Best High-Yield Dividend Stocks for 2025 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report

This page (TSE:PMN) was last updated on 7/12/2025 by MarketBeat.com Staff
From Our Partners